Clinical Applications of PET/MR Imaging

Farshad Moradi; Andrei Iagaru; Jonathan McConathy

doi:10.1016/j.rcl.2021.05.013

Clinical Applications of PET/MR Imaging

Radiol Clin North Am. 2021 Sep;59(5):853-874. doi: 10.1016/j.rcl.2021.05.013.

Authors

Farshad Moradi¹, Andrei Iagaru², Jonathan McConathy³

Affiliations

¹ Department of Radiology, Stanford University, 300 Pasteur Drive, H2200, Stanford, CA 94305, USA. Electronic address: fmoradi@stanford.edu.
² Department of Radiology, Stanford University, 300 Pasteur Drive, H2200, Stanford, CA 94305, USA.
³ Department of Radiology, University of Alabama at Birmingham, 619 19th Street South, JT 773, Birmingham, AL 35249, USA.

PMID: 34392923
DOI: 10.1016/j.rcl.2021.05.013

Abstract

PET/MR imaging is in routine clinical use and is at least as effective as PET/CT for oncologic and neurologic studies with advantages with certain PET radiopharmaceuticals and applications. In addition, whole body PET/MR imaging substantially reduces radiation dosages compared with PET/CT which is particularly relevant to pediatric and young adult population. For cancer imaging, assessment of hepatic, pelvic, and soft-tissue malignancies may benefit from PET/MR imaging. For neurologic imaging, volumetric brain MR imaging can detect regional volume loss relevant to cognitive impairment and epilepsy. In addition, the single-bed position acquisition enables dynamic brain PET imaging without extending the total study length which has the potential to enhance the diagnostic information from PET.

Keywords: Molecular neuroimaging; Oncologic imaging; PET/MR imaging.

Publication types

Review

MeSH terms

Humans
Magnetic Resonance Imaging / trends*
Multimodal Imaging / trends*
Positron-Emission Tomography / trends*
Radiopharmaceuticals
Whole Body Imaging / trends*

Substances

Radiopharmaceuticals